Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Medicine for Asthama
As per available reports about 144 relevant journals, 20 Conferences, and 12 workshops are presently dedicated exclusively to Medicine for Asthama and about 106 articles are being published on Medicine for Asthama.
Asthma is a common chronic inflammatory disease of the airways which is characterized by variable and recurring symptoms, bronchospasm and reversible airflow obstruction. Some of the very common symptoms of asthma are continuous coughing, chest tightness and shortness of breath. It is thought that asthma is caused by a combination of genetic and environmental factors. The diagnosis of asthma is usually based on the pattern of symptoms and body’s response to therapy over time and spirometer. However, asthma may also be classified into two categories- atopic (extrinsic) or non-atopic (intrinsic). Medicines for asthma play a key role in gaining good control of our condition. It is thought to be a chronic disease that involves inflammation of the airways superimposed with recurrent episodes of decreased airflow and mucus production. That is why, controlling your asthma is crucial in avoiding asthma attacks and living an active life. However two broad categories of medication which is most commonly used for asthma are- Controller Medication and Quick Relief Medication. Controller medication is the most important type of therapy for most people with asthma as it prevents asthma attacks on an ongoing basis. Airways are less inflamed and less likely to react to triggers as a result of controller medications. An important type of anti-inflammatory medication for people suffering from asthma has been provided by corticosteroids. Main function of asthma drugs is to reduce inflammation, mucus production and swelling in the airways. Many patients combine use of an inhaled steroid with an inhaled long-acting beta-agonist (LABA).
OMICS International Organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. OMICS International Conferences will enhance the knowledge of all the participants in different fields and will be a varied combination of eminent speakers, industry professionals, social activist, students and research scholars. OMICS International pharma conferences are the novel developments and to consider, and conflate ideas and realities through practical experiences.
Scope and Importance:
The scope allows more air to come in and out of the lungs by rapidly opening the airways. Because of it, there is an improvement in breathing. More than twice a week indicates that your asthma is not well controlled by using these as a rescue medication. However in order to prevent symptoms in people who have exercise-induced asthma SABAs are also used prior to exercises. The long-term use of inhaled corticosteroids may slightly delay growth among children. However, the advantages of using these medications to maintain good asthma control generally outweigh their risks. Asthma attacks and other problems linked to poorly controlled asthma can be checked by regular use of inhaled corticosteroids. It has been seen that corticosteroids don't generally cause serious side effects. The side effects caused generally include mouth irritation, throat irritation and oral yeast infections. In spite of using a metered dose inhaler, spacer should be used and mouth should be rinsed with water after each use to reduce the amount of drug that can be swallowed and absorbed into your body.Due to increase in problem of asthma, there is increment in conferences of asthma throughout the world. Asthma conferences have been quickly organized throughout the globe in order to reduce the sufferings.
Market Analysis:
The global market for commercial Medicine for Asthama reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.The Medicine for Asthama segment was worth $2.3 billion in 2010 and $2.5 billion in 2011; the segment will further reach nearly $4 billion by 2016 increasing at a compound annual growth rate (CAGR) of 9.6% from 2010 to 2016 and Medicine for Asthama segment reached $2.5 billion in 2010 and is expected to reach $3 billion in 2011; it will further grow to and reach $3.8 billion by 2016 at a compound annual growth rate (CAGR) of 4.9% from 2010 to 2016.
International symposium and workshops
1. World Asthma Day Symposia (May 14, 2014, Australia),
2. Allergy practice manager symposia (26April, 2015)
3. Workshop on Asthma- Workshop Model of Asthma 2015 (February 5-6, 2015, Hannover),
4. Practice Management Workshop (July 17-19, 2015),
5. Asthma Management Workshop (29 August 2014, SA),
6. International Workshop on Lung Health (February 19-21, 2015, Valencia)
List of Best International Conferences:
Societies
1. Canadian Lung Association
2. American Lung Association
3. American Academy of Asthma
4. Asthma Society of Canada
5. Asthma Society of Ireland
6. Asthma and Allergy Foundation of America
7. American Thoracic Society, British Thoracic Society.
Companies
1. Glaxosmithkline plc
2. MAP Pharmaceuticals
3. Merck & Co. Inc.,
4. AstraZeneca plc
5. Roche Holdings Ltd
6. Genentech Inc.
7. Sepracor
8. Schering-Plough Corp.,
9. Sanofi-Aventis, Theravance Inc.
This page will be updated regularly.
This page was last updated on November 22, 2024
